Mostrando 3 resultados de: 3
Filtros aplicados
Origen
scopus(3)
Combined methylphenidate and fluoxetine treatment in adolescent rats significantly impairs weight gain with minimal effects on skeletal development
ArticleAbstract: Methylphenidate (MP) is frequently prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHPalabras claves:Fluoxetine, methylphenidate, RAT, Skeletal developmentAutores:Areikat N., Chirokikh A.A., Connor C., David Edward Komatsu, Duque E., Hadjiargyrou M., Jones R., Thanos P.K., Uddin S.M.Z.Fuentes:scopusBehavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
ReviewAbstract: The majority of animal studies on methylphenidate (MP) use intraperitoneal (IP) injections, subcutanPalabras claves:ADHD, animal model, Behavior, dopamine, methylphenidate, neurochemistry, Psychostimulant, ritalinAutores:Ahmed R., Arnavut E., Badgaiyan R.D., Blum K., Carvalho A., David Edward Komatsu, Hadjiargyrou M., Lee W.X., Senior D., Thanos P.K.Fuentes:scopusWeekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects
ArticleAbstract: Methylphenidate (MP) is a commonly prescribed psychostimulant for Attention Deficit Hyperactivity DiPalabras claves:anxiety, Attention Deficit Hyperactivity Disorder, Depression, methylphenidate, Psychostimulant, ritalin, SOCIAL BEHAVIORAutores:Carias E., David Edward Komatsu, Fricke D., Hadjiargyrou M., Kalinowski L., Martin C., Popoola D., Smith L., Somanesan R., Thanos P.K., Vijayashanthar A.Fuentes:scopus